Profile of volatile organic compound (VOCs) as a biomarker on exhaled breath for diagnosis of pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210818001

Enrollment

248

Registered

2021-08-18

Start date

2021-08-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer patient and non-pancreatic cancer patient Volatile organic compounds (VOCs), Artificial Intelligence (AI), TD-GC/FAIMS technique, Pancreatic cancer

Interventions

Participants ranging of 18-80 years, pancreatic cancer patients were newly diagnosed with pancreatic cancer from histopathology or typical radiologic images techniques, pancreatic cancer had recurrent

Diagnostic,Diagnostic

pancreatic cancer,non-pancreatic cancer

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Participants in ranging of 18-80 years, pancreatic cancer patients were diagnosis pancreatic cancer from histopathology or typical radiologic images techniques, pancreatic cancer had recurrent or with history of other cancers were excluded.

Exclusion criteria

Exclusion criteria: pancreatic cancer had recurrent or with history of other cancers, Patient is unable to give informed consent, Non-fasting patients, Patients use of antibiotics, probiotics and lactulose for preceding 4 weeks

Design outcomes

Primary

Measure	Time frame
pattern of VOCs 2years level of VOCs	—

Secondary

Measure	Time frame
pattern of VOCs for stage pancreatic cancer 2 years level of VOCs	—

Countries

Thailand

Contacts

Public Contactthanikan sukaram

King Chulalongkorn Memorial Hospital

thanikannoonsukaram@gmail.com0956414197

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026